Geron Corp (GERN) option IV into FDA Oncologic Drugs Advisory Committee meeting

Go back to Geron Corp (GERN) option IV into FDA Oncologic Drugs Advisory Committee meeting
Geron Corp (NASDAQ: GERN) Delayed: 1.33 +0.07 (5.56%)
Previous Close $1.26    52 Week High $5.30 
Open $1.28    52 Week Low $1.81 
Day High $1.36    P/E N/A 
Day Low $1.27    EPS $-0.35 
Volume 10,095,386